Cryoport Inc asset turnover ratio, the ability of Cryoport Inc 's assets to generate revenue in the first quarter 2026, increased sequentially to 0.24 in the first quarter (Mar 31 2026), yet the ratio remained below the average, as CYRX's position remain challenging.

Within sector 94 more businesses have achieved higher asset turnover ratio. While Asset turnover ratio total ranking has improved so far during the I Quarter 2026, to 2225, from total ranking in the fourth quarter 2025 at 2499.

Asset Turnover Ratio Definition

Select the Comparisons :

None ▼

Select the Ratio:

Asset Turnover▼

None ▼

Asset Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

CYRX Asset Turnover Ratio	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter	(Mar 31 2025) I. Quarter
Y / Y Asset Change	9.11 %	8.74 %	10.34 %	-9.2 %	-25.77 %
Y / Y Revenue Change	16.47 %	-23.65 %	-21.94 %	-21.08 %	-24.82 %
Asset Turnover Ratio (TTM)	0.24	0.23	0.26	0.28	0.29
CYRX's Total Ranking	# 2225	# 2499	# 1162	# 2156	# 1981
Seq. Asset Change	-0.18 %	-1.21 %	0.05 %	10.59 %	-0.52 %
Seq. Revenue Change	5.17 %	2.75 %	-2.69 %	10.76 %	-31.06 %

Asset Turnover Ratio Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 95
Healthcare Sector	# 324
Overall Market	# 2225

Asset Turnover Ratio Statistics
High	Average	Low
8.29	6.22	5.2
(March 31, 2015)		(Mar 31 2026)

CYRX Company Profile • Back to CYRX Efficiency Comparisons • Compare CYRX Asset Turnover Ratio to its Competitors

Companies with similar Asset Turnover Ratio for the quarter ending Mar 31 2026, within Healthcare Sector	Asset Turnover Ratio	Revenues for 12 Months ending Mar 31 2026	Assets at quarter ending Mar 31 2026
Resmed Inc	0.66	$ 5,504.590 Millions	$ 8,360.355 Millions
Urogen Pharma Ltd	0.66	$ 139.526 Millions	$ 211.977 Millions
Ani Pharmaceuticals Inc	0.66	$ 923.706 Millions	$ 1,403.375 Millions
Dentsply Sirona Inc	0.66	$ 3,681.000 Millions	$ 5,595.000 Millions
Pulmonx Corporation	0.66	$ 87.841 Millions	$ 133.681 Millions
Align Technology inc	0.66	$ 4,094.492 Millions	$ 6,250.128 Millions
Allurion Technologies Inc	0.65	$ 12.357 Millions	$ 19.019 Millions
Eli Lilly And Company	0.65	$ 72,249.500 Millions	$ 111,227.500 Millions
Tg Therapeutics Inc	0.65	$ 700.349 Millions	$ 1,079.932 Millions
Immucell Corporation	0.65	$ 29.035 Millions	$ 44.773 Millions
Staar Surgical Co	0.65	$ 290.375 Millions	$ 449.235 Millions
Bioaffinity Technologies Inc	0.64	$ 5.660 Millions	$ 8.801 Millions
Novocure Limited	0.64	$ 674.414 Millions	$ 1,049.830 Millions
Akebia Therapeutics Inc	0.64	$ 232.404 Millions	$ 362.208 Millions
Stereotaxis Inc	0.64	$ 30.801 Millions	$ 48.260 Millions
Sarepta Therapeutics Inc	0.64	$ 2,184.184 Millions	$ 3,425.472 Millions
Halozyme Therapeutics Inc	0.64	$ 1,508.458 Millions	$ 2,368.293 Millions
Procept Biorobotics Corporation	0.64	$ 321.012 Millions	$ 504.934 Millions
Ss Innovations International Inc	0.63	$ 48.259 Millions	$ 76.082 Millions
Macrogenics Inc	0.63	$ 157.083 Millions	$ 247.724 Millions
Zoetis Inc	0.63	$ 9,509.000 Millions	$ 15,064.750 Millions
Twist Bioscience Corporation	0.63	$ 409.479 Millions	$ 649.941 Millions
10x Genomics Inc	0.63	$ 637.614 Millions	$ 1,016.114 Millions
Vericel Corporation	0.63	$ 292.086 Millions	$ 465.619 Millions
Viskase Holdings inc	0.62	$ 87.424 Millions	$ 140.040 Millions
Anika Therapeutics Inc	0.62	$ 116.123 Millions	$ 186.694 Millions
Heartflow Inc	0.62	$ 189.487 Millions	$ 306.810 Millions
Neuraxis Inc	0.61	$ 4.282 Millions	$ 7.004 Millions
Heron Therapeutics Inc	0.61	$ 150.184 Millions	$ 245.783 Millions
Castle Biosciences Inc	0.61	$ 339.920 Millions	$ 558.469 Millions

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.